FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

BORIS KERZNER

Research Profile

Procedures

Concepts & Ideas

Treatment Outcome

Chemicals & Drugs

Disorders

Phenomena

Safety

Living Beings

Co-author Network

Publications

TOP 3
Alexander V Murray; Jon E Stek; Timothy A Sausser; Keith S Reisinger; Jin Xu; BORIS KERZNER; Ivan S F Chan; William W Wang; Paula W Annunziato; Janie Parrino
Safety and tolerability of zoster vaccine in adults ≥60 years old.
Harold E Bays; Yun-Jung Choi; David B Karpf; BORIS KERZNER; Ronald M Krauss; Thomas Littlejohn; Sue Naim; Sherwyn Schwartz; Xueyan Wang; Brian K Roberts
MBX-8025, a novel peroxisome proliferator receptor-delta agonist: lipid and other metabolic effects in dyslipidemic overweight patients treated with and without atorvastatin.
BORIS KERZNER; Alexander V Murray; Eric Cheng; Rudy Ifle; Peter R Harvey; Mark Tomlinson; Julie L Barben; Kimberly Rarrick; Jon E Stek; Mi-Ok Chung; Florian Schodel; William W B Wang; Jin Xu; Ivan S F Chan; Jeffrey L Silber; Katia Schlienger
Safety and immunogenicity profile of the concomitant administration of ZOSTAVAX and inactivated influenza vaccine in adults aged 50 and older.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of BORIS KERZNER (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Alexander V Murray; Jon E Stek; Timothy A Sausser; Keith S Reisinger; Jin Xu; BORIS KERZNER; Ivan S F Chan; William W Wang; Paula W Annunziato; Janie Parrino
Safety and tolerability of zoster vaccine in adults ≥60 years old.
Human vaccines 2011;7(11):1130-6.
2011: Harold E Bays; Yun-Jung Choi; David B Karpf; BORIS KERZNER; Ronald M Krauss; Thomas Littlejohn; Sue Naim; Sherwyn Schwartz; Xueyan Wang; Brian K Roberts
MBX-8025, a novel peroxisome proliferator receptor-delta agonist: lipid and other metabolic effects in dyslipidemic overweight patients treated with and without atorvastatin.
The Journal of clinical endocrinology and metabolism 2011;96(9):2889-97.
2007: BORIS KERZNER; Alexander V Murray; Eric Cheng; Rudy Ifle; Peter R Harvey; Mark Tomlinson; Julie L Barben; Kimberly Rarrick; Jon E Stek; Mi-Ok Chung; Florian Schodel; William W B Wang; Jin Xu; Ivan S F Chan; Jeffrey L Silber; Katia Schlienger
Safety and immunogenicity profile of the concomitant administration of ZOSTAVAX and inactivated influenza vaccine in adults aged 50 and older.
Journal of the American Geriatrics Society 2007;55(10):1499-507.
2006: Roxanne A Rodney; Daniel Sugimoto; Bernard Wagman; Franklin Zieve; BORIS KERZNER; John Strony; Bo Yang; Ramachandran Suresh; Enrico Veltri
Efficacy and safety of coadministration of ezetimibe and simvastatin in African-American patients with primary hypercholesterolemia.
Journal of the National Medical Association 2006;98(5):772-8.
2004: Michael H Davidson; Christie M Ballantyne; BORIS KERZNER; Lorenzo Melani; Philip T Sager; Leslie Lipka; John Strony; Ramachandran Suresh; Enrico Veltri
Efficacy and safety of ezetimibe coadministered with statins: randomised, placebo-controlled, blinded experience in 2382 patients with primary hypercholesterolemia.
International journal of clinical practice 2004;58(8):746-55.
2003: BORIS KERZNER; John Corbelli; Stephan Sharp; Leslie Lipka; Lorenzo Melani; LeBeaut Pierre Alexandre; Ramachandran Suresh; Pabak Mukhopadhyay; Enrico Veltri
Efficacy and safety of ezetimibe coadministered with lovastatin in primary hypercholesterolemia.
The American journal of cardiology 2003;91(4):418-24.
2002: Moti L Kashyap; Mark E McGovern; Kathleen Berra; John R Guyton; Peter O Kwiterovich; Wayne L Harper; Phillip D Toth; Laurence K Favrot; BORIS KERZNER; Stephen D Nash; Harold E Bays; Phillip D Simmons
Long-term safety and efficacy of a once-daily niacin/lovastatin formulation for patients with dyslipidemia.
The American journal of cardiology 2002;89(6):672-8.
1978: P Penovich; J P Morgan; BORIS KERZNER; F Karch; D Goldblatt
Double-blind evaluation of deanol in tardive dyskinesia.
JAMA : the journal of the American Medical Association 1978;239(19):1997-8.